A challenging case of recalcitrant Hyper-IgE syndrome successfully treated with omalizumab

A challenging case of recalcitrant Hyper-IgE syndrome successfully treated with omalizumab

Hyper-IgE syndrome (HIES) is a rare group of primary immunodeficiency diseases characterized by elevated IgE levels, eosinophilia, recurrent pyoderma, ear infection, eczematous dermatitis, and pulmonary infection. The treatment depends on the clinical presentation of the disease. The eczematous skin...

Full description

Bibliographic Details
Main Authors: Rashid Shahid, Swetalina Pradhan, Suvesh Singh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Paediatric Dermatology
Subjects:
eosinophil
hyper-ige syndrome
ige
omalizumab
recurrent infection
Online Access:http://www.ijpd.in/article.asp?issn=2319-7250;year=2022;volume=23;issue=4;spage=318;epage=321;aulast=Shahid

Internet

http://www.ijpd.in/article.asp?issn=2319-7250;year=2022;volume=23;issue=4;spage=318;epage=321;aulast=Shahid

Similar Items